IMV News and Press, IMV Inc. From 05/08/19

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today joins with World Ovarian Cancer Coalition and Ovarian Cancer Canada in recognizing World Ovarian Cancer Day (WOCD). This initiative aims to raise awareness of, and bring hope to, the global challenges...

Abstract on the study accepted at the 2019 ICML Meeting IMV Inc. (Nasdaq: IMV; TSX: IMV), the clinical stage immuno-oncology corporation, today announced that the 2019 International Conference on Malignant Lymphoma (ICML) will publish an abstract on the company’s combination ...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...

Gainers:  Aratana Therapeutics (NASDAQ: PETX ) +37% . India Globalization Capital (NYSEMKT: IGC ) +30% . Regional Health Properties (NYSEMKT: RHE ) +32% . Helen of Troy (NASDAQ: HELE ) +21% . Sonic Automotive (NYSE: SAH ) +15% . Repligen (NASDAQ: RGEN ) +15% . IMV (NASDAQ: IMV )...

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical stage immunotherapy company, announced today that it will hold a conference call and webcast on Friday, May 10, 2019 at 8:00 a.m. ET to discuss the company’s first quarter 2019 financ...

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that two of its abstracts have been accepted for presentation at the upcoming 2019 American Society of Clinical Oncology (ASCO) Annual Meeting , which takes place May 31 – June 4 in Chicag...

IMV Inc. (“IMV” or the “Corporation”) (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company, today issued the following statement regarding recent market activity. In recent weeks, shares of IMV Inc. have come under unwarranted market pressure and ...

The following slide deck was published by IMV Inc. in conjunction with this Read more ...

IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology company today announced that IMV Chief Executive Officer, Frederic Ors will be making an investor presentation at the 2019 Bloom Burton & Co Healthcare Investor Conference , which will be held from April 30 to May 1, 2...